The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Introduction:Chronic graft-versus host disease (GVHD) is a serious complication that develops in 35-50% of patients in the late period after allogeneic hematopoetic stem cell transplantation. About half of the patients are resistant to corticosteroids, which is the first-line treatment of chronic GV...

Full description

Bibliographic Details
Main Authors: Ahmet Sarıcı, Mehmet Ali Erkurt, İrfan Kuku, Emin Kaya, İlhami Berber, Soykan Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecioğlu, Lokman Hekim Tanrıverdi, Sıdıka Gülkan Özkan
Format: Article
Language:English
Published: Galenos Yayinevi 2023-05-01
Series:İstanbul Medical Journal
Subjects:
steroid-resistant graft-versus host disease
ibrutinib
corticosteroids
allo-hsct
chronic gvhd
Online Access: http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-experience-of-brutinib-in-chronic-graft-versus/60513

Internet

http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-experience-of-brutinib-in-chronic-graft-versus/60513

Similar Items